Global Companion Diagnostics Market Size was valued nearly USD 2.17 billion by 2017 and is estimated to reach up to USD xx.xx billion by 2025. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 19.21% during the forecast period that is 2017-2025 because of increasing prevalence of cancer across the globe, incidences of adverse drug reactions, improvements in regulatory guidelines, growing need for targeted therapies, rising cancer incidence across the globe. Asia Pacific led the market in 2018 and is projected to continue the dominance over the forecast period.

Global Companion Diagnostics Market Size, Share Analysis, By Region 2017-2025

Segment Analysis

This research report segments the market for companion diagnostics on the basis of type, disease indication, technology, application, end-user, and region along with forecast of revenue and analyzing trends in each of the regional submarkets.

By Disease Indication Insights: The global companion diagnostics market is segmented on the basis of product such as Breast cancer, Lung Cancer, Colorectal Cancer, Skin cancer and others. Each type is further described in detail in the report with value forecasts between 2017 and 2025 period.

By Technology Analysis: Based on technology the worldwide companion diagnostics market has been categorized into Immunohistochemistry, In Situ Hybridization, Polymerase Chain Reaction, and Genetic Sequencing. Each end-user is further described in detail in the report with value forecasts for the aforementioned period.

End-Use Analysis: On the basis of end-use sectors the global companion diagnostics market is segmented into Hospitals, Diagnostic Laboratories and Others. Each type is further described in detail in the report with value forecasts between 2017 and 2025 period.

Regional Analysis

The global companion diagnostics market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players. In 2018, the North America market led the region and is excepted to register healthy growth rate during the forecast period in terms of revenue due to growing awareness regarding personal health, increasing aged population, technological advancement and high disposable income and affordability for companion diagnostics tests will propel the industry demand and growth during the forecast period. In the global market Asia Pacific was the largest shareholder and generated more than half of the demand in overall global market in 2018 and is projected to its continue impact on the worldwide market during the forecast period because of increasing number of hospitals and diagnostic laboratories, growing need of tailored therapeutics for the elderly population and growing prevalence of life-threatening diseases.

Key Players Landscape

Abbott, Agilent Technologies, bioMérieux, Foundation Medicine, Illumina, MolecularMD (ICON), Myriad Genetic Laboratories, Johnson & Johnson, Qiagen, Roche, Thermo Fisher Scientific and Arup Labortaories these are the major key players in the global companion diagnostics market. Companies also aim to differentiate themselves in the highly competitive global market by expanding their product portfolios in accordance with industry trends and client needs.